Cite
HARVARD Citation
Nørgaard, C. et al. (2022). Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes. European heart journal. 8 (6), pp. 549-556. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nørgaard, C. et al. (2022). Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes. European heart journal. 8 (6), pp. 549-556. [Online].